Cell encapsulation technology as a therapeutic strategy for CNS malignancies

Neuro-Oncology

Volumn 3, Issue 3, 2001, Pages 201-210

  Visted, Therese ^a   Bjerkvig, Rolf ^a   Enger, Per Øyvind ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BIOMATERIAL; GLUCURONIC ACID; HEXURONIC ACID; RECOMBINANT PROTEIN;

BIOREACTOR; BRAIN TUMOR; BRAIN VENTRICLE; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; GENE THERAPY; GENETICS; HUMAN; METHODOLOGY; REVIEW;

ALGINATES; BIOCOMPATIBLE MATERIALS; BIOREACTORS; BRAIN NEOPLASMS; CEREBRAL VENTRICLES; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; RECOMBINANT PROTEINS;

EID: 0035403957     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851700000648     Document Type: Article

References (65)

1. Aebischer, P., Winn, S.R., Tresco, P.A., Jaeger, C.B., and Greene, L.A. (1991) Transplantation of polymer encapsulated neurotransmitter secreting cells: Effect of the encapsulation technique. J. Biomech. Eng. 113, 178-183.
2. Aebischer, P., Scluep, M., Deglon, N., Joseph, J.M., Hirt, L., Heyd, B., Goddard, M., Hammang, J.P., Zurn, A.D., Kato, A.C., Regli, F., and Baetge, E.E. (1996) Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sderosis patients. Nat. Med. 2, 696-699.
3. Bachoud-Levi, A.C., Deglon, N., Nguyen, J.P., Bloch, J., Bourdet, C., Winkel, L., Remy, P., Goddard, M., Lefaucheur, J.P., Brugieres, P., Baudic, S., Cesaro, P., Peschanski, M., and Aebischer, P. (2000) Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF. Hum. Gene Ther. 11, 1723-1729.
4. Biseeglie, V. (1933) Über die antineoplastische Immunitat. Z. Krebsforsch. 40, 141.
5. Brem, H., Piantadosi, S., Burger, P.C., Walker, M., Selker, R., Vick, N.A., Black, K., Sisti, M., Brem, S., Mohr, G., Muller, P., Moravetz, R., and Schold, S.C. (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 345, 1008-1012.
6. Buchser, E., Goddard, M., Heyd, B., Joseph, J.M., Favre. J., de Tribolet, N., Lysaght, M., and Aebischer, P. (1996) Immunoisolated xenogenic chromaffin cell therapy for chronic pain: Initial clinical experience. Anesthesiology 85, 1005-1012.
7. Cherksey, B.D., Sapirstein, V.S., and Geraci, A.L (1996) Adrenal chromaffin cells on microcarriers exhibit enhanced long-term functional effects when implanted into the mammalian brain. Neuroscience 75, 657-664.
8. Chick, W.L., Perna, J.J., Lauris, V., Low, D., Galetti, P.M., Panol, G., Whittemore, A.D., Like, A.A., Colton, C.K., and Lysaght, M.J. (1977) Artificial pancreas using living beta cells: Effects on glucose hemostasis in diabetic rats. Science 197, 780-782.
9. Emerich, D.F., Winn, S.R., Hantraye, P.M., Peschanski, M., Chen, E.Y., Chu, Y., McDermott, P., Baetge, E.E., and Kordower, J.H. (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386, 395-399.
10. Fung, L.K., Ewend, M.G., Sills, A., Sipos, E.P., Thompson, R., Watts, M., Colvin, O.M., Brem, H., and Saltzman, W.M. (1998) Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 58, 672-684.
11. Gossen, M., and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
12. Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C., and Thom, D. (1973) Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett. 32, 195-198.
13. Harsh, G.R., Deisboeck, T.S., Louis, D.N., Hilton, J., Colvin, M., Silver, J.S., Qureshi, N.H., Kracher, J., Finkelstein, D., Chiocca, E.A., and Hochberg, F.H. (2000) Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: A gene-marking and neuropathological study. J. Neurosurg. 92, 804-811.
14. Hasse, C., Schrezenmeir, J., Stinner, B., Schark, C., Wagner, P.K., Neumann, K., and Rothmund, M. (1994) Successful allotransplantation of microencapsulated parathyroids in rats. World J. Surg. 18, 630-634.
15. Hasse, C., Zielke, A., Klöck, G., Schlosser, A., Barth, P., Zimmermann, U., Sitter, H., Lorenz, W., and Rothmund, M. (1998) Amitogenic alginates: Key to first clinical application of microencapsulation technology. World J. Surg. 22, 659-665.
16. 19F-labelled alginate: Production, biocompatibility, stability, and long-term monitoring of functional integrity. Mat.-wiss. u. Werkstofftech. 30, 783-792.
17. Hortelano, G., Al-Hendy, A., Ofosu, F.A., and Chang, P.L. (1996) Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood 87, 5095-5103.
18. Jahr, T.G., Ryan, L., Sundan, A., Lichenstein, H.S., Skjak-Braek, G., and Espevik, T. (1997) Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor. Infect. Immunol. 65, 89-94.
19. Joki, T., Machluf, M., Atala, A., Zhu, J.H., Seyfried, N.T., Dunn, I.F., Abe, T., Carroll, R.S., and Black, P.M. (2001) Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 19, 35-39.
20. Kühtreiber, W.M., Lanza, R.P., and Chick, W.L. (Eds.) (1999) Cell Encapsulation Technology and Therapeutics. Boston: Birkhäuser.
21. Kulseng, B., Thu, B., Espevik, T., and Skjak-Braek, G. (1997) Alginate polylysine microcapsules as immune barrier: Permeability of cytokines and immunoglobulins over the capsule membrane. Cell Transplant. 6, 387-394.
22. Kulseng, B., Skjak-Braek, G., Ryan, L., Andersson, A., King, A., Faxvaag, A., and Espevik, T. (1999) Transplantation of alginate microcapsules: Generation of antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 67, 978-984.
23. Lacy, P.E. (1995) Treating diabetes with transplanted cells. Sci. Am. 273, 50-51 and 54-58.
24. Laham, R., Sellke, F.W., Edelman, E.R., Pearlman, J.D., Ware, J.A., Brown, D.L., Gold, J.P., and Simons, M. (1999) Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100, 1865-1871.
25. Lang, F.F., Fuller, G.N., Prados, M., Sawaya, R., and Yung, W.K.A. (2000) Preliminary results of a phase I clinical trial of adenovirus-mediated p53 gene therapy for recurrent glioma: Biological studies. Neuro-Oncology [serial online], Doc. 00-D129, September 21, 2000. URL: http://neuro-oncology. mc.duke.edu. Neuro-Oncology 2, 277. (Abstract)
26. Lanza, R.P., Kuhtreiber, W.M., Ecker, D.M., Marsh, J.P., and Chick, W.L. (1995) Transplantation of porcine and bovine islets into mice without immunosuppression using uncoated alginate microspheres. Transplant Proc. 27, 3321. (Abstract)
27. Lanza, R.P., Hayes, J.L., and Chick, W.L. (1996) Encapsulated cell technology. Nat. Biotechnol. 14, 1107-1111.
28. Lim, F., and Sun, A.M. (1980) Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908-910.
29. Lindner, M.D., Plone, M.A., Mullins, T.D., Winn, S.R., Chandonait, S.E., Stott, J.A., Blaney, T.J., Sherman, S.S., and Emerich, D.F. (1997) Somatic delivery of catecholamines in the striatum attenuate parkinsonian symptoms and widen the therapeutic window of oral sinemet in rats. Exp. Neurol. 145, 130-140.
30. Lohr, M., Bago, Z.T., Bergmeister, H., Ceijna, M., Freund, M., Gelbmann, W., Gunzburg, W.H., Jesnowski, R., Hain, J., Hauenstein, K., Henninger, W., Hoffmeyer, A., Karle, P., Kroger, J.C., Kundt, G., Liebe, S., Losert, U., Muller, P., Probst, A., Punschel, K., Renner, M., Renz, R., Saller, R., Salmons, B., Schuh, M., Schwendenwein, I., von Rombs, K., Wagner, T., Walter, I. (1999) Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: A phase I/II study. J. Mol. Med. 77, 393-398.
31. Marcel, T., and Grausz, J.D. (1996) The TMC worldwide gene therapy enrollment report. Hum. Gene Ther. 7, 2025-2046.
32. Martinsen, A., Storro, I., and Skjåk-Braek, G. (1992) Alginate as immobilization material. III. Diffusional properties. Biotechnol. Bioeng. 39, 186-194.
33. Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J.M., Wong, V., and Lindsay, R.M. (1994) Arrest of motor neuron disease in wobbler mice cotreated with CNTF and BDNF. Science 265, 1107-1110.
34. Morris, E.R., Rees, D.A., and Thom, D. (1978) Chiroptical and stochiometric evidence of a specific, primary dimerisation process in alginate gelation. Carbohydr. Res. [AU: journal title/abbrev.correct?] 66, 145-154.
35. Onsoyen, E. (1996) Commercial applications of alginates. Carbohydr. Eur. 14, 26-31.
36. Otterlei, M., Ostgaard, K., Skjak-Braek, G., Smidsrod, O., Soon-Shiong, P., and Espevik, T. (1991) Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 10, 286-291.
37. Oyvind, P.E., Visted, T., Thorsen, F., Bjerkvig, R., and Lund-Johansen, M. (1999) Retroviral transfection of the lacZ gene from Liz-9 packaging cells to glioma spheroids. Int. J. Dev. Neurosci. 17, 665-672.
38. Peirone, M., Ross, C.J., Hortelano, G., Brash, J.L., and Chang, P.L. (1998) Encapsulation of various recombinant mammalian cell types in different alginate microcapsules. J. Biomed. Mater. Res. 42, 587-596.
39. Puumalainen, A.M., Vapalahti, M., Agrawal, R.S., Kossila, M., Laukkanen, J., Lehtolainen, P., Viita, H., Paljarvi, L., Vanninen, R., and Yla-Herttuala, S. (1998) Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum. Gene Ther. 9, 1769-1774.
40. Read, T.A., Stensvaag, V., Vindenes, H., Ulvestad, E., Bjerkvig, R., and Thorsen, F. (1999) Cells encapsulated in alginate: A potential system for delivery of recombinant proteins to malignant brain tumours. Int. J. Dev. Neurosci. 17, 653-663.
41. Read, T.A., Sorensen, D.R., Mahesparan, R., Enger, P.Ø., Timpl, R., Olsen, B.R., Hjelstuen, M.H.B., Haraldseth, O., and Bjerkvig, R. (2001) Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 19, 29-34.
42. Renken, A., and Hunkeler, D. (1998) Microencapsulation: A review of polymers and technologies with a focus on bioartificial organs. Polimery 43, 530-539.
43. Ross, C.J., Ralph, M., and Chang, P.L. (1999) Delivery of recombinant gene products to the central nervous system with nonautologous cells in alginate microcapsules. Hum. Gene Ther. 10, 49-59.
44. Sandmair, A.M., Loimas, S., Poptani, H., Vainio, P., Vanninen, R., Turunen, M., Tyynela, K., Vapalahti, M., and Yla-Herttuala, S. (1999) Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment. Acta Neurochir. 141, 867-872.
45. Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H., and Barde, Y.A. (1992) Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360, 757-759.
46. Siebers, U., Horcher, A., Brandhorst, H., Brandhorst, D., Hering, B., Federlin, K., Bretzel, R.G., and Zekom, T. (1999) Analysis of the cellular reaction towards microencapsulated xenogeneic islets after intraperitoneal transplantation. J. Mol. Med. 77, 215-218.
47. Skjak-Braek, C., Grasdalen, H., and Smidsrod, O. (1989) Inhomogeneous polysaccharide ionic gels. Carbohhydr. Polymers 10, 31-54.
48. Soon-Shiong, P., Feldman, E., Nelson, R., Komtebedde, J., Smidsrod, O., Skjak-Braek, G., Espevik, T., Heintz, R., and Lee, M. (1992) Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54, 769-774.
49. Soon-Shiong, P., Heintz, R.E., Merideth, N., Yao, Q.X., Yao, Z., Zheng, T., Murphy, M., Moloney, M.K., Schmehl, M., Harris, M., Mendez, R., Mendez, R.G., Sanford, P.A. (1994) Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343, 950-951.
50. Tamargo, R.J., Myseros, J.S., Epstein, J.I., Yang, M.B., Chasin, M., and Brem, H. (1993) Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain. Cancer Res. 53, 329-333.
51. Thorsen, F., Read, T.A., Lund-Johansen, M., Tysnes, B.B., and Bjerkvig, R. (2000) Alginate-encapsulated producer cells: A potential new approach for the treatment of malignant brain tumors. Cell Transplant 9, 773-783.
52. Thu, B., Bruheim, P., Espevik, T., Smidsrod, O., Soon-Shiong, P., and Skjak-Braek, G. (1996a) Alginate polycation microcapsules. II. Some functional properties. Biomaterials 17, 1069-1079.
53. Thu, B., Bruheim, P., Espevik, T., Smidsrod, O., Soon-Shiong, P., and Skjak-Braek, G. (1996b) Alginate polycation microcapsules. I. Interaction between alginate and polycation. Biomaterials 17, 1031-1040.
54. Tze, W.J., and Chen, L.M. (1977) Long-term survival of adult rat islets of langerhans in artificial capillary culture units. Diabetes 26, 185-191.
55. Valtonen, S., Timonen, U., Toivanen, P., Kalimo, H., Kivipelto, L., Heiskanen, O., Unsgaard, G., and Kuurne, T. (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study. Neurosurgery 41, 44-48.
56. van Schilfgaarde, R., and de Vos, P. (1999) Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J. Mol. Med. 77, 199-205.
57. Wang, T., Lacik, I., Brissova, M., Anilkumar, A.V., Prokop, A., Hunkeler, D., Green, R., Shahrokhi, K., and Powers, A.C. (1997) An encapsulation system for the immunoisolation of pancreatic islets. Nat. Biotechnol. 15, 358-362.
58. Warnick, R.E. (2000) Phase III multicenter trial of GLI 328 HSV-TK gene therapy in newly diagnosed glioblastoma multiforme (GBM). Neuro-Oncology [serial online], Doc. 00-D226, September 21, 2000. URL: http://neuro-oncology.mc.duke.edu. Neuro-Oncology 2, 300. (Abstract)
59. Weber, C.J., Hagler, M., Konieczny, B., Chryssochoos, J., Rajotte, R., Lakkis, F., and Lowry, R. (1995) Encapsulated islet iso-, allo-, and xenografts in diabetic NOD mice. Transplant Proc. 27, 3308-3311. (Abstract)
60. Winn, S.R., Wahlberg, L., Tresco, P.A., and Aebischer, P. (1989) An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp. Neurol. 105, 244-250.
61. Winn, S.R., Hammang, J.P., Emerich, D.F., Lee, A., Palmiter, R.D., and Baetge, E.E. (1994) Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons. Proc. Natl. Acad. Sci. U.S.A. 91, 2324-2328.
62. Wu, Z.G., Shi, Z.Q., Lu, Z.N., Yang, H., Shi, F.Y., Zheng, X.R., and Sun, A.M. (1989) In vitro culture and transplantation of encapsulated human fetal islets as an artificial endocrine pancreas. ASAIO Trans. 35, 736-738.
63. Zekorn, T., Siebers, U., Horcher, A., Schnettler, R., Klock, G., Bretzel, R.G., Zimmermann, U., and Federlin, K. (1992) Barium-alginate beads for immunoisolated transplantation of islets of Langerhans. Transplant. Proc. 24, 937-939. (Abstract)
64. Zekorn, T.D., Horcher, A., Mellert, J., Siebers, U., Altug, T.A., Emre, A., Hahn, H.J., and Federlin, K. (1996) Biocompatibility and immunology in the encapsulation of islets of Langerhans (bioartificial pancreas). Int. J. Artif. Organs 19, 251-257.
65. Zimmermann, U., Klock, G., Federlin, K., Hannig, K., Kowalski, M., Bretzel, R.G., Horcher, A., Entenmann, H., Sieber, U., and Zekorn, T. (1992) Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis 13, 269-274.